Deep Track Capital »

Mannkind shares owned by Deep Track Capital

Quarter-by-quarter ownership of Mannkind (MNKD) shares owned by Deep Track Capital from 13F filings

Historical chart of Deep Track Capital investment in Mannkind

Tip: Access up to 7 years of quarterly data

All positions including Mannkind held by Deep Track Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mannkind by Deep Track Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $26M 6.0M 4.26

More positions owned by Deep Track Capital

Guardant Health (GH)
Immunovant (IMVT)
Structure Therapeutics Sponsored Ads (GPCR)
Vaxcyte (PCVX)
Alnylam Pharmaceuticals (ALNY)
Veradermics Common Stock (MANE)
Genmab A/s Sponsored Ads (GMAB)
Tarsus Pharmaceuticals (TARS)
Nuvalent Inc-a (NUVL)
Alkermes SHS (ALKS)
Ocular Therapeutix (OCUL)
BioMarin Pharmaceutical (BMRN)
Nurix Therapeutics (NRIX)
Oruka Therapeutics (ORKA)
Alumis (ALMS)

View all positions for Deep Track Capital

Top funds holding Mannkind

BlackRock
State Street Corporation
Rubric Capital Management
Vanguard Capital Management
Geode Capital Management
Wellington Management Company
Frazier Life Sciences Management
Deep Track Capital
Morgan Stanley
180 Wealth Advisors
FMR
TSP Capital Management Group
AQR Capital Management
Braidwell
Vanguard Portfolio Management

View all funds holding Mannkind